Literature DB >> 31538547

Response to Grech et al.: FLOUX-PMS study sample considerations.

Jop P Mostert1, Jacques De Keyser2,3,4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31538547     DOI： 10.1177/1352458519876027

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy.

Authors:  Mikhail Melnikov; Dmitriy Kasatkin; Anna Lopatina; Nikolay Spirin; Alexey Boyko; Mikhail Pashenkov
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

Review 2.  Th17-cells in depression: Implication in multiple sclerosis.

Authors:  Mikhail Melnikov; Anna Lopatina
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.